Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - AstraZeneca PLC (NYSE:AZN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Options
Upcoming Events
Oct  5Dividend payment of $0.23
Location
15 Stanhope Gate
London W1K 1LN, UK
Phone: (302) 886-4065
Email: investor-relations@astrazeneca.com
Employees (last reported count): 58,000
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Websites
 ·Home Page
 ·Products & Services
 ·Subsidiaries
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 1%
·Institutional: 5% (5% of float)
(252 institutions)
·Net Inst. Selling: 1.73M shares (+2.05%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
AstraZeneca PLC is a pharmaceutical company that provides products to fight disease in important areas of medical need. The Company focuses on seven major therapeutic areas: cancer (oncology); cardiovascular; central nervous system; gastrointestinal; infection; pain control and anesthesia, and respiratory. The Company's non-pharmaceutical businesses include Astra Tech, Salick Health Care, Inc. (SHC) and Cellmark Diagnostics. Astra Tech develops and markets advanced medical devices and implants, focusing primarily on urology, surgery, dental implants and diagnostic imaging. SHC provides a broad range of services to health insurers, oncologists, other specialists and their patients in the United States, principally in the diagnosis and treatment of cancer and the treatment of kidney failure. Cellmark Diagnostics is engaged in DNA fingerprinting outside the United States.
More from Market Guide: Expanded Business Description

Financial Summary
AstraZeneca PLC is an international biosciences company engaged in the R&D, manufacture and marketing of ethical pharmaceuticals, agricultural and specialty chemicals products, and the supply of healthcare services. For the three months ended 3/31/01, revenues rose 3% to $3.99 billion. Net income rose 18% to $782 million. Revenues reflect increased Cardiovascular and Respiratory sales. Earnings also reflect higher margins and increased interest and dividend income.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 4,099; after tax earnings were 1,019. (Preliminary; reported in millions of dollars.)

More from Market Guide: Significant Developments

Officers

Position
Percy BarnevikNon-Exec. Chairman
Tom McKillopCEO
Jonathan SymondsCFO, Director
Barrie ThorpeVP- Operations
Luk VrankenVP of Sales and Marketing
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:AZNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Feb-2001
$42.20 
Recent Price$48.50 
52-Week High
on 28-Sep-2000
$53.25 
Beta0.45 
Daily Volume (3-month avg)432.6K
Daily Volume (10-day avg)438.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+4.6%
52-Week Change
relative to S&P500
+40.3%
Share-Related Items
Market Capitalization$85.6B
Shares Outstanding1.76B
Float1.75B
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 1 on 8-Apr-1998
Per-Share Data
Book Value (mrq*)$5.48 
Earnings (ttm)$1.42 
Earnings (mrq)$0.42 
Sales (ttm)$8.62 
CashN/A 
Valuation Ratios
Price/Book (mrq*)8.85 
Price/Earnings (ttm)34.08 
Price/Sales (ttm)5.63 
Income Statements
Sales (ttm)$16.6B
EBITDA (ttm*)$4.98B
Income available to common (ttm)$2.79B
Profitability
Profit Margin (ttm)16.8%
Operating Margin (ttm)23.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)14.43%
Return on Equity (ttm)27.46%
Financial Strength
Current Ratio (mrq*)1.58 
Debt/Equity (mrq*)0.09 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short2.10M
Percent of Float0.1%
Shares Short
(Prior Month)
2.55M
Short Ratio4.83 
Daily Volume435.0K
ADR Information
Shares/ADR1
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.